Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Tangible Assets |
---|---|---|---|
6/30/2025 | $ 15.58M | $ 1.62M | $ 13.96M |
3/31/2025 | $ 9.28M | $ 1.66M | $ 7.62M |
12/31/2024 | $ 8.5M | $ 1.7M | $ 6.8M |
9/30/2024 | $ 10.47M | $ 1.74M | $ 8.72M |
6/30/2024 | $ 11.82M | $ 1.78M | $ 10.04M |
3/31/2024 | $ 13.36M | $ 1.82M | $ 11.53M |
12/31/2023 | $ 15.26M | $ 1.86M | $ 13.39M |
9/30/2023 | $ 10.92M | $ 1.91M | $ 9.01M |
6/30/2023 | $ 14.11M | $ 1.95M | $ 12.16M |
3/31/2023 | $ 14.73M | $ 1.99M | $ 12.74M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles
(=) Tangible Assets
Tangible Assets for INMED PHARMACEUTICALS INC is calculated as follows: Assets [ $ 6.6M ] - Intangibles [ $ 1.09M ]
(=) Tangible Assets [ $ 5.52M ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.46K |
---|---|
min | $ 0 |
max | $ 5.31B |
average | $ 997.54M |
median | $ 390.77M |
std | $ 1.28B |